MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $856,169 | -19.9% | 3,056 | -23.6% | 0.00% | 0.0% |
| Q1 2024 | $1,068,695 | +19.2% | 4,002 | +3.3% | 0.00% | 0.0% |
| Q4 2023 | $896,598 | +64.5% | 3,875 | +3.8% | 0.00% | – |
| Q3 2023 | $545,167 | -38.1% | 3,733 | -2.0% | 0.00% | -100.0% |
| Q2 2023 | $880,341 | -7.5% | 3,811 | -3.0% | 0.00% | 0.0% |
| Q1 2023 | $952,082 | -21.8% | 3,930 | -6.4% | 0.00% | 0.0% |
| Q4 2022 | $1,218,179 | +389.2% | 4,197 | +9.6% | 0.00% | – |
| Q3 2022 | $249,000 | -10.8% | 3,831 | -1.7% | 0.00% | – |
| Q2 2022 | $279,000 | +32.9% | 3,896 | +82.2% | 0.00% | – |
| Q1 2022 | $210,000 | -17.3% | 2,138 | -32.9% | 0.00% | – |
| Q3 2021 | $254,000 | -29.4% | 3,184 | -13.9% | 0.00% | – |
| Q2 2021 | $360,000 | -42.4% | 3,699 | -30.8% | 0.00% | – |
| Q1 2021 | $625,000 | +4.0% | 5,346 | -1.1% | 0.00% | – |
| Q4 2020 | $601,000 | +56.9% | 5,407 | +67.6% | 0.00% | – |
| Q3 2020 | $383,000 | 0.0% | 3,226 | -4.6% | 0.00% | – |
| Q2 2020 | $383,000 | +81.5% | 3,382 | +45.8% | 0.00% | – |
| Q4 2019 | $211,000 | -10.6% | 2,320 | +2.9% | 0.00% | – |
| Q2 2019 | $236,000 | -15.1% | 2,254 | +1.6% | 0.00% | – |
| Q1 2019 | $278,000 | +20.9% | 2,219 | +8.7% | 0.00% | – |
| Q4 2018 | $230,000 | -88.5% | 2,042 | -78.1% | 0.00% | -100.0% |
| Q3 2018 | $1,993,000 | -18.6% | 9,305 | +6.4% | 0.00% | 0.0% |
| Q2 2018 | $2,447,000 | – | 8,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |